Federal Move to Reclassify Medical Cannabis Raises Brows Across NC and SC

Cannabis Plants Under Federal Review Spotlight

Order applies only to state‑licensed medical marijuana, prompting new questions for both states’ lawmakers and local providers.

SOUTHEASTERN NC & NORTHEASTERN SC — A federal move to reclassify cannabis is prompting new discussion across both Carolinas, where lawmakers have taken sharply different approaches to medical marijuana but share similar questions about how federal rules may shape future policy.

President Donald Trump has moved to reclassify cannabis following a months‑long federal review of the drug and its restrictions. Acting Attorney General Todd Blanche signed an order Thursday reclassifying state‑licensed medical marijuana to a lower federal schedule.

The distinction is important: the order does not reclassify recreational marijuana or cannabis in general. It applies only to medical cannabis products that are regulated under state‑approved medical marijuana programs.

What the federal change does and does not do

The order:

– Reclassifies state‑licensed medical marijuana to a lower federal schedule
– Eases certain federal restrictions on research, taxation, and regulatory coordination
– Does not legalize recreational marijuana
– Does not change federal law for unregulated or non‑medical cannabis
– Does not create or expand state medical programs

States remain responsible for deciding whether to authorize medical cannabis and how to regulate it.

North Carolina: A medical program waiting to launch

North Carolina has approved a tightly regulated medical cannabis framework, but the system has not yet opened to patients. Regulators are still finalizing licensing rules for growers, processors, and dispensaries.

Local officials and prospective operators in Columbus and Brunswick counties say the federal shift could ease several barriers once the state program becomes operational. Those include banking access, insurance coverage, and the ability for medical providers and universities to conduct clinical research.

For patients in southeastern North Carolina, the reclassification raises hopes that the state’s program may move forward with fewer federal complications, especially for residents managing chronic pain, cancer‑related symptoms, and neurological conditions.

South Carolina: No medical program yet, but renewed debate expected

South Carolina does not currently operate a medical marijuana system, though lawmakers have debated the issue for years. Because the federal order applies only to state‑licensed medical marijuana, the change does not immediately affect South Carolina.

However, the shift is expected to influence future legislative discussions

Along the Grand Strand, health providers in Horry and Georgetown counties say the reclassification could eventually support expanded research partnerships if the state authorizes a medical program. Economic development officials note that federal easing may make it easier for future licensed operators to secure financing and insurance.

Residents who have followed South Carolina’s long-running medical cannabis debate say the federal move adds clarity but does not guarantee legislative action in Columbia.

What comes next for the Carolinas

North Carolina’s next steps depend on state regulators finalizing rules and issuing licenses. South Carolina’s future hinges on whether lawmakers choose to revisit medical cannabis legislation during upcoming sessions.

Across both states, the federal reclassification is being viewed as a significant shift that could influence research, healthcare planning, and economic development even as the Carolinas continue to move at different speeds.

BCNews will continue monitoring how the federal action shapes policy discussions and local impacts across Columbus, Brunswick, Horry, and Georgetown counties.

 

© 2026 BCDollarSaver.com. All rights reserved.

About BC News Staff 1406 Articles
Stories are compiled by the BC News & Dollar-Saver Staff

Be the first to comment

Leave a Reply

Your email address will not be published.


*